Physician

Adam Christopher Deising, D.O.

According to 2025 Medicare claims, Adam Deising, D.O. (NPI: 1235285222) practices gastroenterology in the San Diego-Chula Vista-Carlsbad, CA market, with the plurality of this provider's patient population coming from San Diego, CA. This provider's primary affiliated billing organization is SCRIPPS HEALTH (NPI: 1275899072; TIN: 232380812) and primary practice location at 92037-1027. Deising is affiliated with the Scripps Accountable Care Organization, LLC (ACO ID: A3521), participating under the MSSP model.

Deising's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 295 traditional Medicare patients, billed 1,295 HCPCS/CPT codes, and received $96,874 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,029 prescription claims across 173 beneficiaries totaling $604,751 in drug costs, led by Xifaxan (Rifaximin). DME data shows 424 claims. Open Payments data shows 83 records totaling $31,761. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,276 to $96,874. Similarly, Part D prescription costs have moved sharply higher in recent years, from $19,474 to $604,751. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	21	37	$3,276
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	77	211	$17,853
2021	251	607	$66,672
2022	275	696	$76,931
2023	248	694	$75,138
2024	295	1,295	$96,874

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	21	49	$19,474
2021	102	202	$168,283
2022	156	584	$397,243
2023	184	1,112	$788,751
2024	173	1,029	$604,751

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	12	137	$5,048
2023	50	444	$12,292
2024	43	424	$10,878

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	38	38	$204
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	148	284	$138
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	78	103	$105
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	183	359	$13
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	62	67	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xifaxan	Rifaximin	79	2,471	$261,558
Vemlidy	Tenofovir Alafenamide	48	1,440	$70,089
Tacrolimus	Tacrolimus	123	9,750	$24,627
Eliquis	Apixaban	12	600	$10,672
Ursodiol	Ursodiol	49	3,750	$10,382

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7520	Sirolimus, oral, 1 mg	N	N/R	63	$3,306
J7515	Cyclosporine, oral, 25 mg	N	N/R	30	$2,691
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	20	151	$2,658
J7507	Tacrolimus, immediate release, oral, 1 mg	N	11	92	$1,065
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	12	72	$928

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	83	$31,761	Mallinckrodt Hospital Products Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Christopher Deising, D.O.?

Tedicare shows public-source Medicare data for Adam Christopher Deising, D.O. (NPI 1235285222), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Christopher Deising, D.O. have ACO affiliation data?

Adam Christopher Deising, D.O. is shown with ACO affiliation data for Scripps Accountable Care Organization, LLC (MSSP, ACO ID A3521).

What billing organization is linked to Adam Christopher Deising, D.O.?

Adam Christopher Deising, D.O. is linked to SCRIPPS HEALTH (billing NPI 1275899072) in the available physician profile data.

Does Adam Christopher Deising, D.O. have Open Payments data?

Adam Christopher Deising, D.O. has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.